First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report.
Saved in:
| Title: | First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report. |
|---|---|
| Authors: | Wang K; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Taslic CA; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., de Groot P; Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas., Parma MA; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Paula AG; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Caranto M; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shah K; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bose M; Cancer System Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ruoff C; Graduate School of Biomedical Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Karacosta LG; Cancer System Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas., Byers LA; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gay CM; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang J; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Heymach JV; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang B; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. |
| Source: | JTO clinical and research reports [JTO Clin Res Rep] 2025 Dec 12; Vol. 7 (2), pp. 100941. Date of Electronic Publication: 2025 Dec 12 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41584719 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+K%22">Wang K</searchLink>; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Taslic+CA%22">Taslic CA</searchLink>; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22de+Groot+P%22">de Groot P</searchLink>; Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Parma+MA%22">Parma MA</searchLink>; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Paula+AG%22">Paula AG</searchLink>; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Caranto+M%22">Caranto M</searchLink>; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Shah+K%22">Shah K</searchLink>; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Bose+M%22">Bose M</searchLink>; Cancer System Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Ruoff+C%22">Ruoff C</searchLink>; Graduate School of Biomedical Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Karacosta+LG%22">Karacosta LG</searchLink>; Cancer System Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Byers+LA%22">Byers LA</searchLink>; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Gay+CM%22">Gay CM</searchLink>; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Heymach+JV%22">Heymach JV</searchLink>; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Zhang+B%22">Zhang B</searchLink>; Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101769967%22">JTO clinical and research reports</searchLink> [JTO Clin Res Rep] 2025 Dec 12; Vol. 7 (2), pp. 100941. <i>Date of Electronic Publication: </i>2025 Dec 12 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101769967 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-3643 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226663643%22">26663643 </searchLink><i>NLM ISO Abbreviation: </i>JTO Clin Res Rep <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41584719 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jtocrr.2025.100941 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100941 Titles: – TitleFull: First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang K – PersonEntity: Name: NameFull: Taslic CA – PersonEntity: Name: NameFull: de Groot P – PersonEntity: Name: NameFull: Parma MA – PersonEntity: Name: NameFull: Paula AG – PersonEntity: Name: NameFull: Caranto M – PersonEntity: Name: NameFull: Shah K – PersonEntity: Name: NameFull: Bose M – PersonEntity: Name: NameFull: Ruoff C – PersonEntity: Name: NameFull: Karacosta LG – PersonEntity: Name: NameFull: Byers LA – PersonEntity: Name: NameFull: Gay CM – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Heymach JV – PersonEntity: Name: NameFull: Zhang B IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 12 Text: 2025 Dec 12 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2666-3643 Numbering: – Type: volume Value: 7 – Type: issue Value: 2 Titles: – TitleFull: JTO clinical and research reports Type: main |
| ResultId | 1 |